PITNEY BOWES INC /DE/ 8-K

What Happened

• Pitney Bowes Inc. announced on July 21, 2026 that La Vonda Williams was appointed to its Board of Directors. She was named to the Audit Committee, the Governance Committee and the Strategic Review Committee and will receive the Company’s standard non-management director compensation.

Key Details

• Appointment date: July 21, 2026; press release furnished July 27, 2026 (Exhibit 99.1).
• Cash compensation: $200,000 annual retainer plus $20,000 (Audit Committee) and $12,000 (Governance Committee) — $232,000 total annual cash retainer.
• Equity awards: standard annual equity grant equal to $100,000 (prorated to $81,095 for mid-year start) and an additional Strategic Review Committee grant of $278,000 (prorated to $225,446); these restricted stock units vest in one year.
• Other benefits: participation in the Directors’ Deferred Incentive Savings Plan and reimbursement for out-of-pocket Board and Committee meeting expenses.
• Background: Ms. Williams is former CFO of Onegevity Health (2019–2021), previously VP of Equity Derivatives Operations at Goldman Sachs (2014–2019), former COO of Solaire Generation, and served on Altra Industrial Motion’s board (2021–2023). Education: M.B.A. Stanford; B.S. Mechanical Engineering Harvard.
• No related-party transactions or arrangements required to be disclosed under Item 404 of Regulation S-K.

Why It Matters

• A new director with finance and operations experience, including CFO and investment banking roles, can strengthen corporate oversight—notably on the Audit Committee that oversees financial reporting and controls.
• The compensation disclosed (cash plus equity awards, prorated for mid-year start) shows the near-term cost of the appointment but vests in one year, aligning a portion of pay with continued service.
• The additional Strategic Review Committee grant signals active governance involvement in Pitney Bowes’ ongoing strategic review process.